Archive: 12/02/2015

Genomic profiling for cancer of unknown primary site

Genomic profiling of cancer of an unknown primary site (CUP) found at least one clinically relevant genomic alteration in most of the samples tested, an indication of potential to influence and personalize therapy for this ...

page 5 from 9